These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33674357)

  • 1. Transient Depletion of CD4
    Aoki H; Ueha S; Shichino S; Ogiwara H; Shitara K; Shimomura M; Suzuki T; Nakatsura T; Yamashita M; Kitano S; Kuroda S; Wakabayashi M; Kurachi M; Ito S; Doi T; Matsushima K
    Cancer Immunol Res; 2021 Jun; 9(6):624-636. PubMed ID: 33674357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors.
    Shitara K; Ueha S; Shichino S; Aoki H; Ogiwara H; Nakatsura T; Suzuki T; Shimomura M; Yoshikawa T; Shoda K; Kitano S; Yamashita M; Nakayama T; Sato A; Kuroda S; Wakabayashi M; Nomura S; Yokochi S; Ito S; Matsushima K; Doi T
    J Immunother Cancer; 2019 Jul; 7(1):195. PubMed ID: 31340866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR Repertoire Analysis Reveals Mobilization of Novel CD8
    Aoki H; Ueha S; Shichino S; Ogiwara H; Hashimoto SI; Kakimi K; Ito S; Matsushima K
    Front Immunol; 2018; 9():3185. PubMed ID: 30733724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater extent of blood-tumor TCR repertoire overlap is associated with favorable clinical responses to PD-1 blockade.
    Aoki H; Ueha S; Nakamura Y; Shichino S; Nakajima H; Shimomura M; Sato A; Nakatsura T; Yoshino T; Matsushima K
    Cancer Sci; 2021 Aug; 112(8):2993-3004. PubMed ID: 34014607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repertoire Remodeling through CD4
    Yao W; Satpathy AT
    Cancer Immunol Res; 2021 Jun; 9(6):601. PubMed ID: 34365414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
    Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
    J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis.
    Du G; Chen CY; Shen Y; Qiu L; Huang D; Wang R; Chen ZW
    J Immunol; 2010 Oct; 185(7):3940-7. PubMed ID: 20805423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportional Tumor Infiltration of T Cells
    Tsunoda M; Aoki H; Shimizu H; Shichino S; Matsushima K; Ueha S
    Front Immunol; 2021; 12():744381. PubMed ID: 34759926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonality of CD4
    Arakawa A; Vollmer S; Tietze J; Galinski A; Heppt MV; Bürdek M; Berking C; Prinz JC
    Front Immunol; 2019; 10():1336. PubMed ID: 31275310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.
    Aoki H; Shichino S; Matsushima K; Ueha S
    Front Immunol; 2022; 13():807696. PubMed ID: 35154125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal CD4 T-cell receptor repertoire in tonsillar tissue despite perturbed repertoire in peripheral blood in HIV-1 infected individuals.
    Mugnaini EN; Syversen AM; Sannes M; Freng A; Brinchmann JE
    AIDS; 1999 Dec; 13(18):2507-13. PubMed ID: 10630519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-GITR Antibody Treatment Increases TCR Repertoire Diversity of Regulatory but not Effector T Cells Engaged in the Immune Response Against B16 Melanoma.
    Scirka B; Szurek E; Pietrzak M; Rempala G; Kisielow P; Ignatowicz L; Miazek A
    Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):553-564. PubMed ID: 28638937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts.
    Aschauer C; Jelencsics K; Hu K; Heinzel A; Gregorich MG; Vetter J; Schaller S; Winkler SM; Weinberger J; Pimenov L; Gualdoni GA; Eder M; Kainz A; Troescher AR; Regele H; Reindl-Schwaighofer R; Wekerle T; Huppa JB; Sykes M; Oberbauer R
    Front Immunol; 2021; 12():750005. PubMed ID: 34721420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCR repertoire intratumor heterogeneity of CD4
    Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
    Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient.
    Knutson KL; Disis ML
    Hum Immunol; 2002 Jul; 63(7):547-57. PubMed ID: 12072190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).
    Kay N; Leong T; Kyle RA; Greipp P; Van Ness B; Bone N; Oken MM
    Leuk Lymphoma; 1999 Mar; 33(1-2):127-33. PubMed ID: 10194129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia.
    Rezvany MR; Tehrani MJ; Karlsson C; Lundin J; Rabbani H; Osterborg A; Mellstedt H
    Br J Haematol; 2006 Nov; 135(4):475-85. PubMed ID: 16995884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of human TCR junctional region lengths shifts with age in both CD4 and CD8 T cells.
    Hall MA; Reid JL; Lanchbury JS
    Int Immunol; 1998 Oct; 10(10):1407-19. PubMed ID: 9796907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion.
    Schnittman SM; Denning SM; Greenhouse JJ; Justement JS; Baseler M; Kurtzberg J; Haynes BF; Fauci AS
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7727-31. PubMed ID: 2217206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.
    Rudqvist NP; Pilones KA; Lhuillier C; Wennerberg E; Sidhom JW; Emerson RO; Robins HS; Schneck J; Formenti SC; Demaria S
    Cancer Immunol Res; 2018 Feb; 6(2):139-150. PubMed ID: 29180535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.